P2.01-014 ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients With NSCLC and ECOG PS 2
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.1116
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
Elsevier BV